US Drug Enforcement Administration (DEA) has approved the clinical trial to evaluate the therapeutic use of medical marijuana for the treatment of central post-traumatic stress disorder in the United States veterans (PTSD), a non-profit behind the research group, said in a Thursday press release.
Double-blind, placebo-controlled trial is not only different levels of THC and CBD, effective dose and the potential side effects evaluate the effectiveness of marijuana strain, medical marijuana in the treatment-resistant PTSD and 76 US veterans to test the potential benefits of. $ 2M (200 million) grant from Carolla de department of public health and the environment, to provide funds to research.
Group behind the groundbreaking research, interdisciplinary approach to the psychedelic research (MAPS) is, smoked a “plant marijuana in legal prescription drugs say the purpose of approval of DEAN is the first time of the clinical trial to rotation was, “I have received the total approval from the US regulatory authorities, such as the DEA and the food and drug Administration (FDA).
MAPS is, celebrated the news in the announcement of the Thursday.
“We are from we open the FDA and Investigational new drug application in 2010 (IND), has been working towards the approval,” director of clinical research for the Amy Emerson, Executive Director and MAPS public benefit corporation is, we are “, says in a press release we can start collecting the data, this study, we are excited to see overcome the hurdle of approval. This study, administration of smoked marijuana for the symptoms of PTSD, in order to collect information about the risks and rewards, is an important step in order to move our plant drug development program forward at the federal level. ”
The announcement, lawmakers bipartisan group in the United States, urging them to the doctor to be able to recommend medical marijuana to a patient, such as a letter sent to the US State Department of Veterans Affairs in January, PTSD and the potential therapeutic benefits of marijuana of growing interest for the veteran of the next.